(Q35172470)

6 August 2017

1 reference

title

New horizons for stroke prevention: PROGRESS and HOPE. (English)

1 reference

6 August 2017

Philip B Gorelick

1

1 reference

6 August 2017

1 July 2002

1 reference

6 August 2017

1 reference

6 August 2017

1

1 reference

6 August 2017

3

1 reference

6 August 2017

149-156

1 reference

Stroke prevention: windows of opportunity and failed expectations? A discussion of modifiable cardiovascular risk factors and a prevention proposal.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Primary Prevention of Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

The epidemiology of cardiovascular disease in black Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

1 reference

7 January 2021

Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Implications of pulse pressure as a predictor of cardiac risk in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Stiffness of carotid artery wall material and blood pressure in humans: application to antihypertensive therapy and stroke prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Pulse pressure, arterial stiffness, and drug treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Blood pressure and the risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Hypertension, hypertrophy, hormones, and the heart.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Systolic blood pressure and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Impact of high-normal blood pressure on the risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Elevated midlife blood pressure increases stroke risk in elderly persons: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study .

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Aldosterone in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Hypertensive cerebrovascular disease and the renin-angiotensin system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

The renin angiotensin system as a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

The emerging concept of vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Atherosclerosis: risk factors and the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Endothelial function as a determinant of vascular function and structure: a new therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Formulary management of ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Are all angiotensin-converting enzyme inhibitors interchangeable?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Angiotensin-Converting Enzyme Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Blood-pressure lowering for the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

ACE inhibition in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Characteristics of patients with uncontrolled hypertension in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Inadequate Management of Blood Pressure in a Hypertensive Population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

Noncompliance may cause half of antihypertensive drug "failures"

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2802%2900070-4

7 January 2021

10.1016/S1474-4422(02)00070-4

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12849483